Search

everythinglearnresearchcommunity

for

Search:↓

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

A woman with anorexia and Cushing's syndrome improved after tumor removal, highlighting the need to consider hormonal issues in psychiatric conditions.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Injecting certain cells into mice caused hair loss, which was preventable with a specific inhibitor.

A patient's hair loss may be linked to their diabetes medication, Sitagliptin.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

1′S-1′-Acetoxychavicol acetate may help treat hair loss by reducing oxidative stress.

Cynoglossum amabile has medicinal potential but poses safety concerns due to liver toxicity.

Upadacitinib may effectively treat alopecia areata without side effects.

Blocking cholesterol production may help control hair loss in Primary Cicatricial Alopecia by affecting key regulators.

New drugs targeting the JAK-STAT pathway show promise for treating inflammatory skin diseases.

ePUKs could be valuable for regenerative medicine due to their wound healing abilities.

Psoriasis patients have more comorbidities, including autoimmune diseases and other health issues, than those without psoriasis.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Keratin 15 is not a reliable sole marker for identifying epidermal stem cells because it's found in various cell types.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

Women with female-pattern baldness produce more testosterone, but 5a-reductase inhibition treatment won't help.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Drugmakers are optimistic about targeting the Wnt pathway for new treatments despite past challenges.

Dutasteride reduces DHT and improves BPH symptoms more effectively than finasteride.

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

Transplant patients on immunosuppressive medications have a higher risk of skin cancer, and managing this involves balancing medication with cancer risk.

Anabolic steroids and SARMs can cause serious liver damage.